Sarah Jessica Parker Weighs in on EpiPen Controversy

The actress announced she's ending her relationship with Mylan, the manufacturer of the allergy injector whose price hike has sparked outrage.
4:39 | 08/26/16

Coming up in the next {{countdown}} {{countdownlbl}}

Coming up next:



Skip to this video now

Now Playing:


Related Extras
Related Videos
Video Transcript
Transcript for Sarah Jessica Parker Weighs in on EpiPen Controversy
Back now with the growing outrage over epipen's price hike. Sarah Jessica parker has now cut ties with mylan. They raised the price from $100 to there are 600 today. Rebecca Jarvis has more. Reporter: Like so many families, it's a cause near and dear to Sarah Jessica parker because her own son's life-threatening peanut allergy. She's urging mylan to lower to park. This morning, Sarah Jessica parker joining the epipen outrage. A device her own son needs for his life-threatening peanut allergy. His breathing looked labored. His mouth was swelling up the. Reporter: Previously, a vocal pro opponent of mylan. You learn now independent grate this into your life. And you try to get as much information to be ready. Reporter: Nowrying to her.7 million instagram followers, I'm left disappointed, saddened by mylan's actions. I do not condone this decision. I have ended my E relationship with mylan because of it. The pharma company increasing prices more than 400% in just the last eight years. Hitting families like Jennifer Velez, whose 9-year-old daughter, local la, is allergic to peanuts and tree nuts. I was shocked. Last year, it was there are 00. I heard there are 600, I was just played. Reporter: Velez, one of the first to sign this online petition in July asking congress to stop the epipen price gouging. I just don't understand what their justification is. Reporter: Now, mylan responding to the outcry saying it will help subsidize the cost of its device with, among other thing, a $300 instant savings card. A coupon the company says will help insured families who pay out of pocket pay for up to 50% of the cost. Mile listen cover up to $300 for some patients. Mostly those are high deductible insurance plans. A number of lawmakers say the changes don't go far enough. Mylan's CEO heather bresch says the increased costs are a result of a broken system. Saying I'm running a business. I'm a forprofit business. I'm not hide trg that. Let's talk to Dr. Jen Ashton. Pick up on the last point. People see the price. It's a complicated issue. It is. There are multiple almosts involved here. Medical as pepgts. Political aspects. Economic aspects. A lot of people saying this comes down to free market versus government regulation or control. People also asking about why a generic competitor hasn't been brought to market. Several companies have tried that in the last couple of years and gotten caught up in the fda regulatory pro sacess we hear so much about. Now perfect storm here showing the problems we have in our health care system and innocent lives caught in the cross hairs. These pens are so crucial. A life-threatening allergy, you get exposed. Our body releases a substance called histamine. It opens up blood vessels. Drops blood pressure. That leads to an an flaktic reaction. Evtually potentially leading to cardiac arrest. Open nef run counteracts that the. This is a dirt cheap medication that's been around for a long time. This could happen about other life saving treatment. What should parents be thinking about? What can they do? By the way, it's not just kids. This hits home for me. I developed a life-threatening food allergy in my 30s. I had a reaction. These are my epipens. You need them at school, work, at home. Really, you're talking about there are 600, multiply that by three. I think the key here, what we're hearing with parents, taking the lead, through social media. There are some things parents can do. Number one, ask pharmacists, doctors, their insurance companies, about savings, coupons, discounts, rebates. It's worth a try. The other thing is, be vocal. I always say, start local. And then expand your reach to a global. And look for support on social media. We're seeing a phenomenon that has the impact to make some change. Again, so many problems with our health care system. We have to put the term care back into health care. Last word right there. Jen Ashton, thank you very much.

This transcript has been automatically generated and may not be 100% accurate.

{"duration":"4:39","description":"The actress announced she's ending her relationship with Mylan, the manufacturer of the allergy injector whose price hike has sparked outrage.","mediaType":"default","section":"ABCNews/GMA","id":"41661366","title":"Sarah Jessica Parker Weighs in on EpiPen Controversy","url":"/GMA/video/sarah-jessica-parker-weighs-epipen-controversy-41661366"}